-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,935.00(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Nectar Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 23920.0
- ISIN : INE023H01027
-
Today’s Low
22.26 -
Today’s High
24.05

-
Open
23.91 -
Perv Close
23.90 -
52W Low
20.99 -
52W High
56.50
Key Indicators
-
P/E(TTM)
29.99
-
Mar.Cap (₹Cr.)
511.99
-
Div & Yield %
0.00
-
Book Value(₹)
48.06
-
Debt-Equity Ratio
-4.48
-
AGM Date
25-Apr-2025
-
EPS
0.76
-
P/E Ratio
29.99
Financials Ratios
-
Debt-Equity Ratio
0.65
-
Mar.Cap (₹Cr.)
511.99
-
RONW (%)
0.47
-
ROCE (%)
5.96
Score Board
-
Equity (₹ in Cr.)
22.43
-
BV (₹)
48.10
-
Sales( ₹ in Cr.)
1,684.09
-
NP (in Cr.)
4.82
-
NP Var(%)
108.0
-
Div%
0.0
-
CPS (₹)
2.90
-
EPS (₹)
0.20
-
Traded Value (₹ in Lakhs)
511.09
-
52 Week High
56.50
-
52 Week Low
20.99
-
Price BSE
23.0
-
Price NSE
23.00
-
Market Capital( in Cr.)
511.09
-
P/C Ratio
7.90
-
P/E Ratio
107.00
-
Price Vs.BV
0.20
-
11-Mar-2025( 12:24)
Hot Pursuit - Necta... - <P> In a regulatory filing mad...
-
01-Feb-2025( 07:43)
Results - Announcements - Necta... - Net profit of Nectar Lifescien...
-
24-Jan-2025( 04:30)
Corporate News - Necta... - Nectar Lifescience will hold a...
-
14-Nov-2024( 03:13)
Results - Announcements - Necta... - Net profit of Nectar Lifescien...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 1,925.83 | 1,746.56 | 1,924.92 | 1,762.27 | 2,639.28 | 3,114.92 |
Excise Duty | 241.75 | 222.89 | 256.69 | 220.45 | 276.48 | 329.99 |
Net Sales | 1,684.08 | 1,523.67 | 1,668.23 | 1,541.82 | 2,362.80 | 2,784.93 |
Other Income | 14.58 | 43.18 | 11.32 | 3.79 | 4.32 | 6.04 |
Stock Adjustments | 40.21 | 41.64 | -14.97 | -102.80 | 5.25 | 46.99 |
Total Income | 1,738.87 | 1,608.49 | 1,664.58 | 1,442.81 | 2,372.37 | 2,837.96 |
EXPENDITURE : | ||||||
Raw Materials | 1,242.45 | 1,200.84 | 1,207.32 | 1,052.82 | 1,862.83 | 2,268.13 |
Power and Fuel Cost | 129.52 | 127.39 | 101.41 | 84.63 | 92.72 | 103.47 |
Employee Cost | 81.71 | 75.14 | 71.91 | 70.55 | 78.19 | 76.54 |
Other Manufacturing Expenses | 55.30 | 44.88 | 45.09 | 44.16 | 46.39 | 49.87 |
Selling and Administration Expenses | 61.38 | 61.01 | 66.82 | 72.00 | 66.18 | 66.97 |
Miscellaneous Expenses | 2.37 | 1.32 | 1.90 | 31.04 | 3.72 | 3.03 |
Employee Benefit Expenses | 81.71 | 75.14 | 71.91 | 70.55 | 78.19 | 76.54 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,572.73 | 1,510.59 | 1,494.44 | 1,355.19 | 2,150.04 | 2,568.01 |
Operating Profit | 166.13 | 97.91 | 170.13 | 87.63 | 222.33 | 269.94 |
Interest | 87.14 | 79.48 | 78.81 | 112.03 | 125.82 | 148.13 |
Gross Profit | 78.99 | 18.43 | 91.32 | -24.40 | 96.51 | 121.81 |
Depreciation | 60.72 | 59.12 | 56.97 | 60.25 | 60.77 | 63.26 |
Profit Before Tax | 18.27 | -40.69 | 34.35 | -84.65 | 35.74 | 58.55 |
Current Tax | 13.27 | -18.24 | 9.03 | -11.50 | 1.66 | 7.41 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 4.02 | 3.81 |
Reported Net Profit | 5.00 | -22.46 | 25.32 | -73.15 | 30.06 | 47.33 |
Extraordinary Items | 0.18 | 40.51 | 9.41 | -25.41 | 0.22 | -0.17 |
Adjusted Net Profit | 4.82 | -62.97 | 15.91 | -47.74 | 29.84 | 47.50 |
Adjustment below Net Profit | -0.34 | 0.19 | 0.81 | 0.00 | 1.26 | 0.03 |
P & L Balance brought forward | 699.27 | 721.54 | 695.41 | 766.26 | 739.31 | 693.30 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 1.12 | 1.35 | 1.35 |
P & L Balance carried down | 703.93 | 699.27 | 721.54 | 691.99 | 769.28 | 739.31 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 5.00 | 5.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 |
Earnings Per Share-Unit Curr | 0.22 | -1.00 | 1.13 | -3.26 | 1.34 | 2.11 |
Earnings Per Share(Adj)-Unit Curr | 0.22 | -1.00 | 1.13 | -3.26 | 1.34 | 2.11 |
Book Value | 47.68 | 47.47 | 48.46 | 47.30 | 50.59 | 49.26 |
Book Value(Adj)-Unit Curr | 47.68 | 47.47 | 48.46 | 47.30 | 50.59 | 49.26 |